141 results on '"Zalawadiya S"'
Search Results
2. Frailty in Cardiogenic Shock - Prevalence and Utilization of Temporary Mechanical Circulatory Support
3. Cardiac Donation After Circulatory Death Utilizing Normothermic Regional Perfusion: The Three-Year Vanderbilt Experience
4. (305) Characteristics and Outcomes Among Recipients of Dcd Versus Dbd Heart Transplantation - The Vanderbilt Experience
5. Prolonged Warm Ischemic Time is Safe for Cardiac Donation after Circulatory Death
6. (141) Normothermic Regional Perfusion Versus Direct Procurement and Preservation: Is There a Difference for DCD Heart Recipients?
7. Maximally tolerated guideline-directed medical therapy and barriers to optimization in patients with heart failure with reduced ejection fraction: the COAPT trial
8. Use of nutrition literacy scale in elderly minority population
9. Heart-Kidney Transplantation and Hepatitis C Virus Positive Donors
10. Long Term Hematologic and Graft Outcomes After Cardiac Transplant in Al Amyloidosis
11. Demographics and Utilization of Hepatitis C Hearts: A Single Center Experience
12. Desensitization Therapy Among Highly Sensitized LVAD Patients
13. Impact of Donor-Transmitted Hepatitis C Virus on Development of Early Cardiac Allograft Vasculopathy in the Current Era
14. (490) - Frailty in Cardiogenic Shock - Prevalence and Utilization of Temporary Mechanical Circulatory Support
15. (229) - Cardiac Donation After Circulatory Death Utilizing Normothermic Regional Perfusion: The Three-Year Vanderbilt Experience
16. Size Matching and Combined Heart Kidney Transplantation - UNOS Registry Analysis
17. (745) Outcomes and Characteristics of Heart Transplant Recipients Requiring Oral Vasopressor Agents
18. (192) Prolonged Warm Ischemic Time is Safe for Cardiac Donation after Circulatory Death
19. Successful Transplantation of 96 Hepatitis C-positive Donor Hearts in the Era of Direct-Acting Antiviral Therapies
20. Trends in Blood Urea Nitrogen to Creatinine Ratio between Listing and Heart Transplant are Associated with Poor Post-Transplant Outcomes
21. Characteristics of Hepatitis C+ vs Hepatitis C- Donors
22. Readmission Rates and Outcomes at 90 Days in Patients with Perioperative Use of Temporary Circulatory Support at the Time of Heart Transplantation
23. Intracoronary Intimal Thickness in Transplant Recipients of Hepatitis C-Positive Donor Hearts
24. Safety and Efficacy of Percutaneous Ventricular Assist Device Exclusion; a Review of Ten Cases
25. Oversizing Donors - Is It Necessary for ACHD Patients?: An Analysis of the United Network for Organ Sharing Registry
26. Successful Transplantation of 58 Hepatitis C-Exposed Donor Hearts in the Era of Direct-Acting Antiviral Therapies
27. In Hospital Outcomes in Adult Congenital Heart Disease Patients with Fontan Undergoing Heart Transplantation - A Decade Nationwide Analysis from 2004 until 2014
28. Left Thoracotomy Upper Hemisternotomy Left Ventricular Assist Device (LVAD) Implantation Offers Safe, Durable Option for Patients with Prior Sternotomy Undergoing LVAD Implantation
29. Post-Transplant Trends in BNP Levels among Recipients of Heart versus Heart-Kidney Transplantation
30. Incidence of Pancreatitis in Recipients of Hepatitis C Donor Hearts
31. Trends in Renal Function among Heart-Transplant Recipients of Donor-Derived Hepatitis C Virus
32. Intracoronary Intimal Thickness in Recipients of Hepatitis C-Positive Donor Hearts
33. Impact of Anemia on Survival Among Patients with Durable Ventricular Assist Device: An Analysis of the Prevent Study
34. Transplant Center Volume Impacts Survival Among ACHD Patients Undergoing Heart Transplantation - An Analysis of the UNOS Registry
35. Early Outcomes Using Hepatitis C-Exposed Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments
36. Pulmonary Artery Catheterization is Associated with Mortality Decline over Time in Cardiogenic Shock Compared to Patients with Acute Decompensated Heart Failure
37. Trends in Renal Function Among Heart Transplant Recipients of Donors With Hepatitis C
38. Effect of Pre-Durable Mechanical Circulatory Support Device Anemia on Post-Device Implant Mortality
39. Hemoglobin Level at 3 Months Post-Durable Mechanical Circulatory Support Device Implantation and Mortality
40. Standard Dose Doxycycline Does Not Alter von Willebrand Factor Degradation in Patients with CF LVAD
41. (1098) - Transplant Center Volume Impacts Survival Among ACHD Patients Undergoing Heart Transplantation - An Analysis of the UNOS Registry
42. (870) - Early Outcomes Using Hepatitis C-Exposed Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments
43. (474) - Trends in Renal Function Among Heart Transplant Recipients of Donors With Hepatitis C
44. (386) - Impact of Anemia on Survival Among Patients with Durable Ventricular Assist Device: An Analysis of the Prevent Study
45. (248) - Intracoronary Intimal Thickness in Recipients of Hepatitis C-Positive Donor Hearts
46. (85) - Pulmonary Artery Catheterization is Associated with Mortality Decline over Time in Cardiogenic Shock Compared to Patients with Acute Decompensated Heart Failure
47. (1331) - Effect of Pre-Durable Mechanical Circulatory Support Device Anemia on Post-Device Implant Mortality
48. (1321) - Hemoglobin Level at 3 Months Post-Durable Mechanical Circulatory Support Device Implantation and Mortality
49. (5) - Standard Dose Doxycycline Does Not Alter von Willebrand Factor Degradation in Patients with CF LVAD
50. Aortic valve myxoma at the extreme age: a review of literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.